Maureen Gilmore-Hebert
Overview
Explore the profile of Maureen Gilmore-Hebert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
196
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wali V, Gilmore-Hebert M, Mamillapalli R, Haskins J, Kurppa K, Elenius K, et al.
Breast Cancer Res
. 2014 Dec;
16(6):501.
PMID: 25516216
Introduction: Human Epidermal Growth Factor Receptor (ERBB4/HER4) belongs to the Epidermal Growth Factor receptor/ERBB family of receptor tyrosine kinases. While ERBB1, ERBB2 and ERBB3 are often overexpressed or activated in...
2.
Wali V, Haskins J, Gilmore-Hebert M, Platt J, Liu Z, Stern D
Mol Cancer Res
. 2014 May;
12(8):1140-55.
PMID: 24829397
Unlabelled: Associations of ErbB4 (ERBB4/HER4), the fourth member of the EGFR family, with cancer are variable, possibly as a result of structural diversity of this receptor. There are multiple structural...
3.
Gilmore-Hebert M, Ramabhadran R, Stern D
Mol Cancer Res
. 2010 Sep;
8(10):1388-98.
PMID: 20858735
ErbB4 is unusual among receptor tyrosine kinases because some isoforms can be efficiently cleaved at the plasma membrane to release a soluble intracellular domain. The cleavage product has high kinase...
4.
Zhou Y, Yi X, Stoffer J, Bonafe N, Gilmore-Hebert M, McAlpine J, et al.
Mol Cancer Res
. 2008 Aug;
6(8):1375-84.
PMID: 18708368
Although glyceraldehyde-3-phosphate dehydrogenase's (GAPDH) predilection for AU-rich elements has long been known, the expected connection between GAPDH and control of mRNA stability has never been made. Recently, we described GAPDH...
5.
Bonafe N, Gilmore-Hebert M, Folk N, Azodi M, Zhou Y, Chambers S
Cancer Res
. 2005 May;
65(9):3762-71.
PMID: 15867372
The overexpression of the colony-stimulating factor-1(CSF-1) by epithelial ovarian cancer cells enhances invasiveness and metastatic properties, contributing to the poor prognosis of the patients. It has been suggested that CSF-1...
6.
Tangir J, Bonafe N, Gilmore-Hebert M, Henegariu O, Chambers S
Clin Exp Metastasis
. 2005 Feb;
21(6):477-83.
PMID: 15679045
The aggressive behavior of breast cancer cells can at times be modulated by hormonal mechanisms. Exposure to glucocorticoids (GC) has been shown to stimulate the invasiveness, motility and adhesiveness of...
7.
Kluger H, Kluger Y, Gilmore-Hebert M, DiVito K, Chang J, Rodov S, et al.
Lab Invest
. 2004 Feb;
84(3):320-31.
PMID: 14767486
The fms oncogene encodes the macrophage colony-stimulating factor receptor (CSF1R), a transmembrane tyrosine kinase receptor, which is abnormally expressed in breast cancer. Transfection of wild-type CSF1R into HC11 mammary epithelial...